To extend the clinical significance of Tau phosphorylation status in AD, the isogenic iPSC lines were thus differentiated into gluatamatergic neurons, which are severely lost in AD brains, using the Neurogenin 2 (Ngn2) induction method (Supplementary Figure S2E). Here, MAPT is linked to Alzheimer disease.